首頁 > 市場調查報告書 > 醫療設備

體外診斷

市場調查報告書

商品編碼

1542909

全球臨床實驗室服務市場 - 2024-2031

Global Clinical Laboratory Services Market - 2024-2031

出版日期: 2024年08月26日 | 出版商:

DataM Intelligence | 英文 200 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

臨床實驗室服務市場規模

全球臨床實驗室服務市場在2023年達到225.6億美元，預計到2031年將達到4,141.8億美元，2024-2031年預測期間複合年成長率為6.5%。

臨床實驗室是醫療產業不可或缺的一部分，其服務在檢測、診斷和治療疾病方面發揮著至關重要的作用。收集樣本用於檢查和分析體液、組織和細胞。它提供準確的結果，使醫生能夠做出正確的治療決定。它還允許醫生開始/停止或繼續治療過程，70% 的醫療決策是基於實驗室結果。實驗室組織正致力於改進其產品，以縮短測試時間並提高效率；因此，它增加了臨床實驗室的管理。

臨床實驗室服務市場動態

對這些臨床實驗室服務的需求不斷成長、喉癌發病率上升、研發支出不斷增加以及新產品推出的成長預計將推動市場成長。

不斷增加的新產品推出和對臨床實驗室服務的需求將推動市場成長。

全球臨床實驗室服務市場主要是由醫療保健產業對臨床實驗室服務的需求所推動的，這是由於慢性疾病的增加和產品發布數量的增加而產生的。正在各個關鍵領域進行新型診斷分析和臨床試驗的研究。例如，2022 年 7 月，診斷資訊服務提供者 Quest Diagnostics 宣布推出其最新的分子診斷測試，該測試是實驗室開發的，用於幫助診斷猴痘病毒感染。他們計劃很快啟動疾病預防控制中心的正痘病毒測試。

各種最新的技術正在不斷進步，新穎、創新的產品和服務的推出數量也在增加，從而帶來了很高的需求。臨床實驗室的最新創新正在推動市場的成長。例如，2022 年 9 月，Qiagen 宣佈在其 NeuMoDx 檢測產品組合中新增功能，用於與器官移植相關的病毒。其最新檢測方法獲得了歐盟和其他多個國家的 CE 體外診斷標誌。這些新穎的檢測方法用於識別和定量人類皰疹病毒 6 型和 Epstein-Barr 病毒。

醫療保健提供者面臨的高定價壓力將阻礙市場的成長。

然而，醫療保健支付者和提供者面臨的定價壓力以及公眾對資料安全和隱私的擔憂可能會阻礙市場的進步。

COVID-19 對臨床實驗室服務市場的影響分析

疫情對全球金融預期、營運和危機應對策略產生了積極影響。 COVID-19 的爆發嚴重影響了醫療保健產業。臨床實驗室服務經歷了繁榮，其中診斷行業獲利最多。由於用於藥物研究和診斷目的，因此對檢測試劑盒和檢測方法的需求量很大。全球各地正在發生各種合作和合併，促進了市場的成長。例如，2022年10月，生命科學公司Labcorp宣布，他們最近與美國非營利醫療系統Ascension完成了交易，這將導致建立長期的實驗室關係。

臨床實驗室服務市場細分分析

預計臨床化學領域在預測期內（2024-2031）將以最快的複合年成長率成長

臨床化學測試類型細分市場是全球臨床實驗室服務市場中最大的市場佔有者。臨床化學涉及分析血液和尿液樣本，其中進行與酶學和毒理學相關的各種測試。進行各種定量測試來檢查血漿中的一系列物質，例如血糖、荷爾蒙和酵素。由於全球心血管、糖尿病、肝臟、腎臟和血液疾病等目標疾病的發生率增加，臨床化學測試在市場上佔據主導地位。據世界衛生組織稱，2021 年，約有 4.22 億人患有糖尿病，每年約有 150 萬人死亡。每年有 1700 萬人死於傳染病。創新和先進測試的新穎發展正在促進市場成長。例如，羅氏的 Cobas 8000 模組化分析儀系列是一個血清工作區，是一種基於模組的解決方案，適用於廣泛的體外臨床化學和免疫化學診斷測試。它是為高通量實驗室開發的。

臨床實驗室服務市場地域佔有率

北美在全球臨床實驗室服務市場中佔有最大的市場佔有率。

北美在全球臨床實驗室服務市場中佔據主導地位，這主要歸因於公司之間的合作夥伴關係或合作數量不斷增加，以及由於醫療保健基礎設施完善、可支配收入增加以及研發活動投資增加而導致對臨床實驗室服務的需求不斷成長，這些都促進了北美的測試量的佔有率成長率。此外，其廣泛的患者群體、完善的醫療基礎設施、不斷成長的可支配收入以及對研發活動的更高投資都有助於北美佔有率的成長。美國癌症協會估計，2022年美國將新增約190萬癌症病例，其中預計將有609,360人死於癌症。

此外，產品發布數量的增加也是市場成長的原因。其他因素，例如國內生產毛額在醫療保健方面的高支出，刺激了市場的成長。許多關鍵的發展和技術進步都發生在該地區。例如，2022 年 1 月，Exact Sciences 宣布收購預防遺傳學，以擴大患者基因癌症檢測的可用性。

臨床實驗室服務公司與競爭格局

臨床實驗室服務市場與本地和全球公司競爭激烈。 Abbott Laboratories、Bio Reference Laboratories、Exact Sciences Corporation、Myriad Genetics, Inc、Neogenomics Inc、Quest Diagnostics Inc、Siemens Healthineer、Sonic Healthcare Limited、Laboratory Corporation of America、Synlab International GmbH 等。主要參與者正在採取各種成長策略，例如產品發布、併購、合作夥伴關係和協作，為市場的成長做出貢獻。例如，2022年10月，診斷資訊服務供應商Quest Diagnostic宣布同意收購Summa Health實驗室服務LabCare Plus業務的資產。

雅培實驗室

概述：

雅培是一家開發醫療設備和保健產品的跨國公司。它成立於1888年，總部位於美國伊利諾州。他們的產品和服務包括醫療設備、診斷、營養產品和品牌學名藥。

產品組合：

PLEX-ID：它是一種基於分子診斷的技術，整合了質譜和PCR技術，可識別和表徵多種微生物。

關鍵進展：例如，2022 年 5 月，雅培實驗室宣布其 Alinity m STI Assay 獲得美國 FDA 批准。此測試可檢測各種性傳染感染，如果不及時治療，這些感染將成為嚴重的健康併發症，可能導致不孕和癌症。

全球臨床實驗室服務市場報告將提供約 40 多個市場資料表、45 多個圖表和 200（大約）頁。

Clinical laboratories are an integral part of the medical industry, and their services play a crucial role in detecting, diagnosing, and treating disease. Samples are collected to examine and analyze body fluids, tissues, and cells. It provides accurate results that enable physicians to make the right therapeutic decisions. It also allows physicians to start/stop or continue the course of treatment, and 70% of medical decisions are based on laboratory results. Laboratory organizations are focusing on improving their products to shorten the test duration and increase efficiency; thus, it increases the management of clinical laboratories.

Clinical Laboratory Services Market Dynamics

The increasing demand for these Clinical Laboratory Services, the rising incidence of larynx cancer, the increasing research and development expenditure and growth in novel product launches are expected to drive market growth.

The increasing novel product launches and demand for clinical laboratory services will drive market growth.

The global market for clinical laboratory services is primarily driven by the healthcare industry's demand for clinical laboratory services due to increasing chronic disorders and the rising number of product launches. Studies are being conducted on novel diagnostic assays and clinical trials in various key areas. For instance, in Jul 2022, Quest Diagnostics, a diagnostic information service provider, announced its latest molecular diagnostic test that is lab-developed to aid the diagnosis of monkeypox virus infection. They are planning to launch their CDC's orthopoxvirus test soon.

Various latest technological advancements are taking place, and the number of novel, innovative product and service launches is increasing, leading to high demand. The latest innovations by clinical laboratories are driving the growth of the market. For instance, In Sep 2022, Qiagen announced novel additions to their NeuMoDx assay portfolio for the viruses associated with organ transplants. Its latest assays got CE-In Vitro Diagnostic mark for European Union and various other countries. The novel assays are for identifying and quantifying human herpes virus 6 and Epstein-Barr virus.

High pricing pressure faced by healthcare providers will hamper the market's growth.

However, the pricing pressure faced by healthcare payers and providers and public concerns related to data security and privacy may hinder market progress.

COVID-19 Impact Analysis on Clinical Laboratory Services Market

The pandemic has positively impacted global financial expectations, operations and crisis response strategy. The COVID-19 outbreak has severely impacted the healthcare industry. Clinical laboratory services have experienced a boom, and the diagnosis sector has profited the most. The demand of test kits and assays are in high demand since they are used for drug research and diagnostic purposes. Various collaborations and mergers are happening worldwide, boosting the market's growth. For instance, in Oct 2022, Labcorp, a life-sciences company, announced that they recently completed transactions with Ascension, a non-profit health system in the United States, that would lead to forming a laboratory relationship for a long period.

Clinical Laboratory Services Market Segmentation Analysis

The clinical chemistry segment is expected to grow at the fastest CAGR during the forecast period (2024-2031)

The clinical chemistry test type segment is the highest market holder in the global clinical laboratory services market. Clinical chemistry deals with analyzing blood and urine samples in which various tests related to enzymology and toxicology are performed. Various quantitative tests are performed to examine the range of substances, such as blood sugar, hormones and enzymes in the plasma. The clinical chemistry test dominates the market due to an increase in the occurrence of target diseases such as cardiovascular, diabetes, liver, kidney, and blood disorders globally. According to the WHO, in 2021, around 422 million people had diabetes, and approximately 1.5 million died yearly. Every year 17 million people die due to infectious diseases. The novel development of innovative and advanced tests is increasing market growth. For instance, Roche's Cobas 8000 modular analyzer series is a serum work area that is a module-based solution for a broad range of in vitro clinical chemistry and immunochemistry diagnostic testing. It is developed for high-throughput labs.

Clinical Laboratory Services Market Geographical Share

North America holds the largest market share of the global clinical laboratory services market.

North America dominates the global clinical laboratory services market, primarily attributed to the increasing number of partnerships or collaborations between companies and the rising demand for clinical laboratory services due to established healthcare infrastructure, rising disposable income, and higher investment in R&D activities contribute to North America's share growth% of test volume. Moreover, its broad base patient population and the established healthcare infrastructure and rising disposable income, and higher investment in R&D activities contribute to the growth of North America's share. The American Cancer Society estimated that about 1.9 million new cancer cases would be registered in the U.S. in 2022, of which 609,360 people are expected to die from cancer.

Moreover, the growing number of product launches is responsible for the market's growth. Other factors, such as the high spending of GDP on healthcare, stimulate the market's growth. Many key developments and technological advancements are taking place based in this region. For Instance, in Jan 2022, Exact Sciences announced its acquisition of prevention genetics to expand the availability of genetic cancer testing for patients.

Clinical Laboratory Services Companies and Competitive Landscape

The clinical laboratory services market is highly competitive with local and global companies. Abbott Laboratories, Bio Reference Laboratories, Exact Sciences Corporation, Myriad Genetics, Inc, Neogenomics Inc, Quest Diagnostics Inc, Siemens Healthineer, Sonic Healthcare Limited, Laboratory Corporation of America, Synlab International GmbH and more. The key players are adopting various growth strategies such as product launches, mergers & acquisitions, partnerships, and collaborations, contributing to the market's growth. For instance, in Oct 2022, Quest Diagnostic, a diagnostic information service provider, announced its agreement to acquire assets of Summa Health's business of laboratory services LabCare Plus.

Abbott Laboratories

Overview:

Abbott is a multinational company that develops medical devices and healthcare products. It was founded in 1888 and is headquartered in Illinois, United States. Their products and services include medical devices, diagnostics, nutritional products and branded generic medicines.

Product Portfolio:

PLEX-ID: It is molecular diagnostic-based technology that integrates mass spectrometry and PCR technology and identifies and characterizes a wide range of microorganisms.

Key Development: For instance, in May 2022, Abbott Laboratories announced that its Alinity m STI Assay got cleared by U.S. FDA. This test detects various sexually transmitted infections that, if not treated on time, become serious health complications that can lead to infertility and cancer.

The global clinical laboratory services market report would provide access to approximately 40+ market data tables, 45+ figures, and 200 (approximate) pages.

1. Market Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

4.1. Market Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. The rising novel product launches
  - 4.1.1.2. Increasing demand for clinical laboratory services
- 4.1.2. Restraints:
  - 4.1.2.1. High pricing pressure faced by the healthcare provider
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Forces
5.2. Unmet Needs
5.3. Supply chain Analysis
5.4. Regulatory Analysis

6. COVID-19 Analysis

6.1. Analysis of Covid-19 on the Market
- 6.1.1. Before COVID-19 Market Scenario
- 6.1.2. Present COVID-19 Market Scenario
- 6.1.3. After COVID-19 or Future Scenario
6.2. Pricing Dynamics Amid Covid-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During the Pandemic
6.5. Manufacturer's Strategic Initiatives
6.6. Conclusion

7. By Test Type

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
- 7.1.2. Market Attractiveness Index, By Test Type
7.2. Clinical Chemistry *
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
7.3. Microbiology
7.4. Serology
7.5. Hematology
7.6. Pathology
7.7. Molecular Diagnostics
7.8. Others

8. By Application

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 8.1.2. Market Attractiveness Index, By Application
8.2. Preclinical & Clinical Trial-Related Services*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
8.3. Bioanalytical & Lab Chemistry Services
8.4. Drug Discovery & Development Related Services
8.5. Cell & Gene Therapy Related Services
8.6. Others

9. By End-User

9.1. Introduction
- 9.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By End-User
- 9.1.2. Market Attractiveness Index, By End-User
9.2. Hospital-based Labs*
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
9.3. Clinic-based Labs
9.4. Stand-alone Labs

10. By Region

10.1. Introduction
- 10.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
- 10.1.2. Market Attractiveness Index, By Region
10.2. North America
- 10.2.1. Introduction
- 10.2.2. Key Region-Specific Dynamics
- 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
- 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), End-User
- 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.2.6.1. The U.S.
  - 10.2.6.2. Canada
  - 10.2.6.3. Mexico
10.3. Europe
- 10.3.1. Introduction
- 10.3.2. Key Region-Specific Dynamics
- 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
- 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), End-User
- 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.3.6.1. Germany
  - 10.3.6.2. The U.K.
  - 10.3.6.3. France
  - 10.3.6.4. Italy
  - 10.3.6.5. Spain
  - 10.3.6.6. Rest of Europe
10.4. South America
- 10.4.1. Introduction
- 10.4.2. Key Region-Specific Dynamics
- 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
- 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), End-User
- 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.4.6.1. Brazil
  - 10.4.6.2. Argentina
  - 10.4.6.3. Rest of South America
10.5. Asia Pacific
- 10.5.1. Introduction
- 10.5.2. Key Region-Specific Dynamics
- 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
- 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), End-User
- 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.5.6.1. China
  - 10.5.6.2. India
  - 10.5.6.3. Japan
  - 10.5.6.4. Australia
  - 10.5.6.5. Rest of Asia Pacific
10.6. Middle East and Africa
- 10.6.1. Introduction
- 10.6.2. Key Region-Specific Dynamics
- 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Test Type
- 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), End-User
- 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country

11. Competitive Landscape

11.1. Key Developments and Strategies
11.2. Company Share Analysis
11.3. Product Benchmarking
11.4. List of Key Companies to Watch

12. Company Profiles

12.1. Abbott Laboratories
- 12.1.1. Company Overview
- 12.1.2. Product Portfolio and Description
- 12.1.3. Key Highlights
- 12.1.4. Financial Overview
12.2. Bio Reference Laboratories
12.3. Exact Sciences Corporation
12.4. Myriad Genetics, Inc
12.5. Neogenomics Inc
12.6. Quest Diagnostics Inc
12.7. Siemens Healthineer
12.8. Sonic Healthcare Limited
12.9. Laboratory Corporation of America
12.10. Synlab International GmbH(*LIST NOT EXHAUSTIVE)